Andrew J. Barkmeier, M.D.

  1. Ophthalmologist

Publications

  1. Fortes BH, Dalvin LA, Hogan WJ, Patnaik MM, Choong GM, Salomao DR, Barkmeier AJ, Bhatti MT. Isolated T-cell acute lymphoblastic leukemic optic disc infiltration. Am J Hematol. 2021 Sep 24 Epub 2021 Sept 24
    View PubMed
  2. Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ, Jampol LM, MacCumber MW, Maguire MG, Maturi RK, Salehi-Had H, Rofagha S, Sun JK, Martin DF, DRCR Retina Network. Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. Ophthalmology. 2021 May 11 [Epub ahead of print]
    View PubMed
  3. Starr MR, Mahr MA, Smith WM, Iezzi R, Barkmeier AJ, Bakri SJ. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 Apr 20; 229:194-199 [Epub ahead of print]
    View PubMed
  4. Hainsworth DP, Gao X, Bebu I, Das A, Olmos de Koo L, Barkmeier AJ, Tamborlane W, Lachin JM, Aiello LP, Diabetes Control and Complications Trial and Follow-up Epidemiology of Diabetes Interventions and Complications Research Group. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Ophthalmology. 2021 Apr; 128 (4):554-560 Epub 2020 Sept 14
    View PubMed
  5. Hutton DW, Glassman AR, Stein JD, Bressler NM, Sun JK, DRCR Retina Network. Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V. Am J Ophthalmol. 2021 Mar 10 [Epub ahead of print]
    View PubMed
  6. Maloney MH, Payne SR, Herrin J, Sangaralingham LR, Shah ND, Barkmeier AJ. Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice. Ophthalmology. 2021 Mar; 128 (3):417-424 Epub 2020 Aug 08
    View PubMed
  7. Beaulieu WT, Glassman AR, Baker CW, Maguire MG, Johnson CA, Melia M, Sun JK, DRCR Retina Network. Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial. Transl Vis Sci Technol. 2021 Mar 1; 10 (3):3
    View PubMed
  8. Grosinger AJ, Nicholson BP, Shah SM, Pulido JS, Barkmeier AJ, Iezzi R, Bakri SJ. Time to Unplanned Return to the Operating Room and Associated Risk Factors in Patients With Surgical Retinal Detachment Repair. Am J Ophthalmol. 2021 Feb 21; 229:18-25 [Epub ahead of print]
    View PubMed
  9. Platt SM, Barkmeier AJ. Endoscope-assisted scleral buckle procedure. Int J Retina Vitreous. 2020 Nov 11; 6 (1):52
    View PubMed
  10. Starr MR, Mahr MA, Iezzi R, Barkmeier AJ, Bakri SJ. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF. Semin Ophthalmol. 2020 May 18; 35 (4):205-209 Epub 2020 July 28
    View PubMed
  11. Glassman AR, Baker CW, Beaulieu WT, Bressler NM, Punjabi OS, Stockdale CR, Wykoff CC, Jampol LM, Sun JK, DRCR Retina Network. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2020 Apr 1; 138 (4):341-349
    View PubMed
  12. Starr MR, Barkmeier AJ, Engman SJ, Kitzmann A, Bakri SJ. Telemedicine in the Management of Exudative Age-Related Macular Degeneration within an Integrated health care System. Am J Ophthalmol. 2019 Dec; 208:206-210. Epub 2019 Mar 21.
    View PubMed
  13. Bressler NM, Odia I, Maguire M, Glassman AR, Jampol LM, MacCumber MW, Shah C, Rosberger D, Sun JK, DRCR Retina Network. Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial. JAMA Ophthalmol. 2019 Sep 1; 137 (9):977-985
    View PubMed
  14. Maloney MH, Schilz SR, Herrin J, Sangaralingham LR, Shah ND, Barkmeier AJ. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice. Ophthalmology. 2019 Jul; 126 (7):1007-1015 Epub 2018 Oct 04
    View PubMed
  15. Singman EL, Boland MV, Tian J, Green LK, Srikumaran D. Supervision and autonomy of ophthalmology residents in the outpatient clinic in the United States II: a survey of senior residents. BMC Med Educ. 2019 Jun 13; 19 (1):202 Epub 2019 June 13
    View PubMed
  16. Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK. Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. JAMA. 2019 May 21; 321 (19):1880-1894
    View PubMed
  17. Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, White NH, Danis R, Wallia A, Gao X, Barkmeier AJ, Das A, Patel S, Gardner TW, Lachin JM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2019 May; 42 (5):875-882 Epub 2019 Mar 04
    View PubMed
  18. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol 2019 Jan 22 [Epub ahead of print]
    View PubMed
  19. Mansukhani SA, Barkmeier AJ, Bakri SJ, Iezzi R, Pulido JS, Khanna CL, Bennett JR, Hodge DO, Sit AJ. The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based Study. Am J Ophthalmol. 2018 Sep; 193:143-155 Epub 2018 June 27
    View PubMed
  20. Starr MR, Mahr MA, Barkmeier AJ, Iezzi R, Smith WM, Bakri SJ. Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid. Am J Ophthalmol. 2018 Aug; 192:91-97. Epub 2018 May 23.
    View PubMed
  21. Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. Ophthalmology. 2018 Jul; 125 (7):1054-1063 Epub 2018 Mar 07
    View PubMed
  22. Dalvin LA, Salomao DR, Iezzi R, Barkmeier AJ. Subconjunctival Exposure to Carbopol Causes Chronic Histiocytic Inflammatory Response in Rabbits. Transl Vis Sci Technol. 2018 May; 7 (3):9 Epub 2018 May 31
    View PubMed
  23. Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, Melia M, Wells JA 3rd, Diabetic Retinopathy Clinical Research Network. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2018 Mar 1; 136 (3):257-269
    View PubMed
  24. Glassman AR, Liu D, Jampol LM, Sun JK, Diabetic Retinopathy Clinical Research Network . Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2018 Mar 1; 59 (3):1199-1205
    View PubMed
  25. Veverka KK, Hatt SR, Leske DA, Brown WL, Barkmeier AJ, Lezzi R Jr, Iezzi R Jr, Holmes JM. Prevalence and Associations of Central-Peripheral Rivalry-Type Diplopia in Patients With Epiretinal Membrane. JAMA Ophthalmol. 2017 Dec 1; 135 (12):1303-1309
    View PubMed
  26. Atchison EA, Omar AF, Iezzi R, Barkmeier AJ, Bakri SJ. OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC. Retina. 2017 Jul; 37 (7):1371-1376
    View PubMed
  27. Javey G, Rigi M, Barkmeier AJ, Heffez JL, Carvounis PE. SCLEROTOMY LEAKAGE IN TRANSCONJUNCTIVAL SMALL-GAUGE PARS PLANA VITRECTOMY: Effect of Removing the Cannula Over the Light Pipe. Retina. 2017 Jun; 37 (6):1079-1083
    View PubMed
  28. Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthalmology. 2017 Mar; 124 (3):352-358 Epub 2016 Nov 24
    View PubMed
  29. Jampol LM, Glassman AR, Bressler NM, Wells JA, Ayala AR, Diabetic Retinopathy Clinical Research Network. Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 01; 134: (12).
    View PubMed
  30. Barkmeier AJ, Salomao DM, Baratz KH. MANAGEMENT OF MYCOBACTERIUM CHELONAE ENDOPHTHALMITIS WITH COMPLETE SURGICAL DEBRIDEMENT. Retina. 2016 Dec; 36 (12):2440-2442
    View PubMed
  31. Dalvin LA, Garcia MD, Salomao DR, Iezzi R, Barkmeier AJ. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel. Ophthalmology. 2016 Oct; 123 (10):2262-3 Epub 2016 June 17
    View PubMed
  32. Ross EL, Hutton DW, Stein JD, Bressler NM, Jampol LM, Glassman AR, Diabetic Retinopathy Clinical Research Network. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. JAMA Ophthalmol. 2016 Aug 01; 134: (8)888-96.
    View PubMed
  33. Roddy GW, Kreuter JD, Koh BD, Barkmeier AJ. Central retinal vein occlusion after plateletpheresis. Transfusion. 2016 Jun; 56 (6):1258
    View PubMed
  34. Erie JC, Barkmeier AJ, Hodge DO, Mahr MA. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States. Ophthalmology. 2016 Jun; 123 (6):1257-62 Epub 2016 Mar 12
    View PubMed
  35. Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW, Diabetic Retinopathy Clinical Research Network . Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology.2016 Jun;123:(6):1351-9.
    View PubMed
  36. Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E, Comparison of Age-related Macular Degeneration Treatments Trials Research Group . Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2016 Apr; 123: (4)858-64.
    View PubMed
  37. Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2016 Apr; 123: (4)865-75.
    View PubMed
  38. Maxfield SD, Barkmeier AJ. Exudative Macular Detachment After Viral Illness With Rash. JAMA Ophthalmol. 2016 Mar; 134: (3)335-6.
    View PubMed
  39. Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2016 Mar; 123: (3)609-16.
    View PubMed
  40. Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmol. 2016 Feb; 134: (2)127-34.
    View PubMed
  41. Atchison E, Barkmeier A. The Role of Systemic Risk Factors in Diabetic Retinopathy. Curr Ophthalmol Rep. 2016; 4 (2):84-89 Epub 2016 Mar 25
    View PubMed
  42. Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2015 Sep; 122 (9):1846-53.e5 Epub 2015 July 02
    View PubMed
  43. Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015 Mar 26; 372: (13)1193-203.
    View PubMed
  44. Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group//Comparison of Age-related Macular Degeneration Treatments Trials CATT Research. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2015 Feb; 122: (2)391-398.e5.
    View PubMed
  45. Kapoor KG, Barkmeier AJ, Bakri SJ. Optical coherence tomography in retinal arterial occlusions: case series and review of the literature. Semin Ophthalmol. 2015 Jan; 30(1):74-9. Epub 2013 Sep 27.
    View PubMed
  46. Carvounis PE, Albini TA, Barkmeier AJ, Tsilimbaris M. Advances in retinal therapeutics. J Ophthalmol. 2015; 2015:515193 Epub 2015 Mar 09
    View PubMed
  47. Kapoor KG, Barkmeier AJ. Xanthic Scotoma. JAMA Ophthalmology.2014 Nov;132:(11):1354.
    View PubMed
  48. Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014 Oct; 121: (10)1956-65.
    View PubMed
  49. Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG, CATT Research Group. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul; 158: (1)128-135.e10.
    View PubMed
  50. Kapoor KG, Hodge DO, St Sauver JL, Barkmeier AJ. Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study. Ophthalmology. 2014 Jun; 121 (6):1269-73 Epub 2014 Jan 28
    View PubMed
  51. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group . VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol. 2014 May; 132: (5)521-7.
    View PubMed
  52. Chen GW, Barkmeier AJ. Perioperative management of antithrombotic medications in vitreoretinal surgery. Int Ophthalmol Clin.2014 Spring;54:(2):199-13.
    View PubMed
  53. Nicholson BP, Barkmeier AJ. Bevacizumab and diabetic vitrectomy. Int Ophthalmol Clin. 2014 Spring; 54(2):111-26.
    View PubMed
  54. Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP, DCCT/EDIC Research Group. Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. Ophthalmology. 2013 Dec; 120 (12):2580-2586 Epub 2013 July 24
    View PubMed
  55. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B, DCCT/EDIC Research Group. Diabetes control and complications trialepidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013 Dec; 62: (12)3976-86.
    View PubMed
  56. Kavoussi SC, Shetlar DJ, Barkmeier AJ, Carvounis PE. Invasive conjunctival squamous cell carcinoma presenting with serous retinal detachment. Can J Ophthalmol 2013 Dec; 48 (6):e158-9
    View PubMed
  57. Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013 Sep; 120: (9)1860-70.
    View PubMed
  58. Kapoor KG, Baratz KH, Barkmeier AJ. Laser photocoagulation of an avulsed persistent pupillary membrane vessel causing recurrent hyphaema. Clin Exp Ophthalmol 2013 Jul; 41 (5):513-5 Epub 2013 Jan 24
    View PubMed
  59. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF, Comparison of AMD Treatments Trials Research Group. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013 Mar; 120: (3)593-9.
    View PubMed
  60. Ying GS, Huang J, Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2013 Jan; 120: (1)122-9.
    View PubMed
  61. Singh R, Reddy DM, Barkmeier AJ, Holz ER, Ram R, Carvounis PE. Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity. Br J Ophthalmol. 2012 Nov; 96(11):1395-8. Epub 2012 Aug 24.
    View PubMed
  62. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd, Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul; 119: (7)1388-98.
    View PubMed
  63. Pulido JS, Barkmeier AJ, Leavitt JA, Lewis RA. Screening for hydroxychloroquine toxicity. Ophthalmology 2012 Jan; 119 (1):207; author reply 207-8
    View PubMed
  64. Barkmeier AJ, Carvounis PE, Holz ER. Long-term observation of exposed scleral exoplant without topical antibiotic prophylaxis. Retinal Cases & Brief Reports.2011 Winter;5:(1):16-17.
    View PubMed
  65. Barkmeier AJ, Kadikoy H, Holz ER, Carvounis PE. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab. Eur J Ophthalmol. 2011 Jul-Aug; 21 (4):506-8
    View PubMed
  66. CATT Research Group , Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med.364:(20):1897-908.
    View PubMed
  67. Barkmeier AJ, Carvounis PE. Retinal pigment epithelial tears and the management of exudative age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):94-103.
    View PubMed
  68. Mojumder DK, Concepcion FA, Patel SK, Barkmeier AJ, Carvounis PE, Wilson JH, Holz ER, Wensel TG. Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11):5796-803. Epub 2010 May 26.
    View PubMed
  69. Kadikoy H, Barkmeier A, Peck B, Carvounis PE. Persistent photopsia following course of oral voriconazole. J Ocul Pharmacol Ther. 2010 Aug; 26(4):387-8.
    View PubMed
  70. Ernst BJ, Barkmeier AJ, Akduman L. Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. International Ophthalmology.2010 Jun;30:(3):267-70.
    View PubMed
  71. Barkmeier AJ, Feman SS. Frosted branch angiitis secondary to herpes simplex virus infection progressing to acute retinal necrosis. Retinal Cases & Brief Reports.2009 Winter;3:(1):36-7.
    View PubMed
  72. Barkmeier AJ, Nicholson BP, Akduman L. Effectiveness of laser photocoagulation in clinically significant macular edema with focal vs. diffuse parafoveal thickening on optical coherence tomography Ophthalmic Surg Lasers Imaging.2009 Sept-Oct;40:(5):472-9.
    View PubMed
  73. Barkmeier AJ, Akduman L, Ernst BJ, Oz O. Regression of choroidal neovascularization secondary to pathologic myopia after intravitreal injection of bevacizumab. Retina-Vitreus. 2009; 17:222-4.
  74. Barkmeier AJ, Akduman L. Bevacizumab (Avastin) in ocular processes other than choroidal neovascularization. Ocul Immunol Inflamm.2009 Mar-April;17:(2):109-17.
    View PubMed
  75. Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonyglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol pharmacol.2004 Apr;65:(4):999-1007.
    View PubMed
  76. Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgdo MA, Barkmeier AJ, Klck DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and porstaglandins by a novel ratmicroglial cell line. J Neuroimmunol.2004 Apr;149:(1-2):130-41.
    View PubMed
PST-20225865